These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 3328677

  • 1. [Management of refractory and fulminating colitis].
    Turunen U.
    Duodecim; 1987; 103(14):890-6. PubMed ID: 3328677
    [No Abstract] [Full Text] [Related]

  • 2. [Long-term therapy in ulcerative colitis and Crohn's disease].
    Malchow H.
    Fortschr Med; 1979 Aug 02; 97(29):1253-60. PubMed ID: 457018
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease.
    Klotz U, Maier K, Fischer C, Heinkel K.
    N Engl J Med; 1980 Dec 25; 303(26):1499-502. PubMed ID: 6107853
    [Abstract] [Full Text] [Related]

  • 4. [New therapeutic data in inflammatory colitis].
    Karsenti P.
    Ann Gastroenterol Hepatol (Paris); 1996 Dec 25; 32(1):10. PubMed ID: 8669802
    [No Abstract] [Full Text] [Related]

  • 5. [Crohn's disease. Has there been progress in its treatment?].
    Berenguer J.
    Med Clin (Barc); 1984 Jun 09; 83(2):61-4. PubMed ID: 6147447
    [No Abstract] [Full Text] [Related]

  • 6. [Pharmacological bases of therapy with 5-ASA].
    Beltrán B, Martínez-Cuesta MA, Calatayud S, Hinojosa J, Esplugues JV.
    Gastroenterol Hepatol; 1997 Jun 09; 20(6):322-34. PubMed ID: 9296850
    [No Abstract] [Full Text] [Related]

  • 7. Which component of sulphasalazine is active in rheumatoid arthritis?
    Pullar T, Hunter JA, Capell HA.
    Br Med J (Clin Res Ed); 1985 May 25; 290(6481):1535-8. PubMed ID: 2860942
    [Abstract] [Full Text] [Related]

  • 8. 5-Aminosalicylic acid or sulphapyridine. Which is the active moiety of sulphasalazine in rheumatoid arthritis?
    Taggart AJ, Neumann VC, Hill J, Astbury C, Le Gallez P, Dixon JS.
    Drugs; 1986 May 25; 32 Suppl 1():27-34. PubMed ID: 2877851
    [Abstract] [Full Text] [Related]

  • 9. Active therapeutic moiety of sulphasalazine.
    van Hees PA, van Tongeren JH, Bakker JH, van Lier HJ.
    Lancet; 1978 Feb 04; 1(8058):277. PubMed ID: 74700
    [No Abstract] [Full Text] [Related]

  • 10. 5-Aminosalicylic acid for the treatment of inflammatory bowel disease.
    Dew MJ, Evans BK, Rhodes J.
    Gastroenterology; 1984 Aug 04; 87(2):480-1. PubMed ID: 6735091
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [5-Aminosalicylic acid--a new therapeutic possibility in chronic inflammatory bowel disease].
    Hartmann F.
    Leber Magen Darm; 1986 Jan 04; 16(1):20-7. PubMed ID: 3515082
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Current therapeutic possibilities in chronic inflammatory intestinal diseases].
    Schölmerich J.
    Praxis (Bern 1994); 1995 Jan 10; 84(2):29-33. PubMed ID: 7839043
    [Abstract] [Full Text] [Related]

  • 16. [Mesalazine in Crohn disease].
    Linnestad P.
    Tidsskr Nor Laegeforen; 1990 Oct 20; 110(25):3252. PubMed ID: 2256041
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Will there be a next generation of sulfasalazine?
    Goldman P.
    Gastroenterology; 1982 Nov 20; 83(5):1138-41. PubMed ID: 6126420
    [No Abstract] [Full Text] [Related]

  • 19. [Inflammatory bowel diseases].
    Kruis W.
    Dtsch Med Wochenschr; 2004 Sep 03; 129 Suppl 2():S73-5. PubMed ID: 15368174
    [No Abstract] [Full Text] [Related]

  • 20. [Chronic inflammatory intestinal diseases in childhood].
    Binder V.
    Ugeskr Laeger; 1978 Jul 24; 140(30):1831-2. PubMed ID: 695046
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.